In vitro study shows altered luminescence and reduced antibacterial activity of silica-coated silver sulfide nanoparticles in cell models, highlighting bioimaging utility.
This work investigates the effect of a thin silica shell deposited on Ag 2 S nanoparticles capped with thioglycolic acid (TGA) on their physicochemical, optical, cytotoxic, and antibacterial properties. FTIR spectroscopy confirmed that TGA molecules were adsorbed on the Ag 2 S surface in their ionic form, with free carboxylic terminal groups, while TEOS molecules were chemisorbed to form Ag 2 S-TGA-SiO 2 core-shell nanostructures. The XRD analysis revealed the monoclinic crystalline structure of Ag 2 S and confirmed the successful formation of the SiO 2 shell. TEM images showed nearly spherical particles with an average diameter of 5.1 nm, while EDX spectra indicated a higher silver content in silica-coated nanoparticles. DLS results exhibited bimodal size distributions of 4.2- 67.5 nm for Ag 2 S-TGA and 13.3- 90.8 nm for Ag 2 S-TGA-SiO 2 nanostructures, indicating the presence of small clusters and some degree of aggregation. Photoluminescence (PL) spectra, recorded under 488 nm excitation from 15 to 65 °C, showed temperature-dependent NIR emissions below 1000 nm, suitable for optical nanothermometry. Ag 2 S-TGA displayed a broad emission around 915 nm, whereas Ag 2 S-TGA-SiO 2 exhibited an additional yellow/green band (∼600 nm) and a redshift of the main NIR band from 894 to 914 nm with temperature. The average PL lifetimes were 2.56 ns and 3.20 ns for Ag 2 S-TGA and Ag 2 S-TGA-Si 2 O, respectively. The MTT assays on U-87 MG cells revealed over 80% viability after 24h, confirming biocompatibility. Antibacterial tests showed that Ag 2 S-TGA exhibited stronger activity ( 𝑀 𝐼 𝐶 = 2 0 𝛭 𝑔 / 𝑚 𝑙 against E. coli and Salmonella ) compared with Ag 2 S-TGA-SiO 2 ( 𝑀 𝐼 𝐶 = 1 6 6 6 and 61 μg/ml, respectively). Fluorescence microscopy confirmed nanoparticle internalization and homogeneous intracellular distribution, highlighting their potential for bioimaging and antibacterial applications.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: